General Pharmacology — MCQs

General Pharmacology Indian Medical PG Practice Questions and MCQs

Question 21: Which of the following is a prodrug of cetirizine?

A. Foxefenadone
B. Terfenadine
C. Hydroxyzine (Correct Answer)
D. Azelastine

Explanation: **Explanation:** **1. Why Hydroxyzine is the Correct Answer:** Hydroxyzine is a first-generation H1-receptor antagonist. It undergoes extensive hepatic metabolism via the enzyme **alcohol dehydrogenase** to form its active carboxylic acid metabolite, **Cetirizine**. Since Cetirizine is the active form responsible for a significant portion of the drug's antihistaminic effect, Hydroxyzine is considered the prodrug of Cetirizine. This conversion explains why Cetirizine (a second-generation agent) is less sedating; it is a polar metabolite that does not cross the blood-brain barrier as readily as its parent compound, Hydroxyzine. **2. Analysis of Incorrect Options:** * **A. Fexofenadine:** This is the active metabolite of **Terfenadine**. It is not a prodrug but a second-generation antihistamine itself. * **B. Terfenadine:** This is a prodrug of **Fexofenadine**. It was withdrawn from the market because the parent drug (Terfenadine) caused QT interval prolongation and *Torsades de Pointes* when its metabolism was inhibited (e.g., by erythromycin or ketoconazole). * **D. Azelastine:** This is a second-generation antihistamine primarily used as a nasal spray or ophthalmic drop for allergic rhinitis and conjunctivitis. It is not a prodrug of cetirizine. **3. NEET-PG High-Yield Pearls:** * **Metabolite Pairs:** Always remember: Hydroxyzine → Cetirizine; Terfenadine → Fexofenadine; Loratadine → Desloratadine. * **Safety Profile:** Cetirizine is unique among second-generation antihistamines as it can cause mild sedation in some patients, unlike Fexofenadine, which is considered non-sedating even at high doses. * **Clinical Use:** Hydroxyzine is frequently used for its sedative and anti-pruritic properties in dermatological conditions and anxiety.

Question 22: All of the following drugs are used as immunosuppressants except?

A. Glucocorticoids
B. Cyclosporin
C. Cephalosporin (Correct Answer)
D. Azathioprine

Explanation: ### Explanation The correct answer is **Cephalosporin** because it is an **antibiotic**, not an immunosuppressant. #### 1. Why Cephalosporin is the Correct Choice Cephalosporins are **Beta-lactam antibiotics** derived from the fungus *Acremonium*. They work by inhibiting bacterial cell wall synthesis (binding to Penicillin-Binding Proteins). They have no inherent activity in suppressing the human immune system and are used to treat bacterial infections. #### 2. Analysis of Other Options (Immunosuppressants) * **Glucocorticoids (Option A):** These are the most commonly used immunosuppressants. They act by inhibiting the expression of multiple inflammatory genes (NF-κB pathway), decreasing cytokine production (IL-1, IL-2, IL-6), and causing T-cell apoptosis. * **Cyclosporin (Option B):** A **Calcineurin inhibitor**. It binds to cyclophilin to inhibit calcineurin, preventing the dephosphorylation of NFAT (Nuclear Factor of Activated T-cells). This specifically blocks the synthesis of **Interleukin-2 (IL-2)**, a key driver of T-cell proliferation. * **Azathioprine (Option D):** A **Cytotoxic/Antimetabolite** drug. It is a prodrug of 6-mercaptopurine (6-MP) that inhibits purine synthesis, thereby preventing the proliferation of rapidly dividing B and T lymphocytes. #### 3. NEET-PG High-Yield Pearls * **Confusion Point:** Students often confuse **Cyclosporin** (Immunosuppressant) with **Cephalosporin** (Antibiotic) or **Cycloserine** (Anti-TB drug) due to similar nomenclature. * **Cyclosporin Side Effects:** Remember the "6 H's"—Hypertrichosis (hirsutism), Hyperplasia (gingival), Hypertension, Hyperlipidemia, Hyperkalemia, and **Hepatotoxicity/Nephrotoxicity**. * **Azathioprine Interaction:** It is metabolized by **Xanthine Oxidase**. Therefore, its dose must be reduced by 50-75% if the patient is also taking **Allopurinol** to avoid life-threatening bone marrow suppression.

Question 23: Loading dose of a drug primarily depends on which pharmacokinetic parameter?

A. Volume of distribution (Correct Answer)
B. Clearance
C. Rate of administration
D. Half-life

Explanation: **Explanation:** The **Loading Dose (LD)** is a large initial dose given to achieve the **target plasma concentration ($C_p$)** rapidly. It is primarily determined by the **Volume of Distribution ($V_d$)**. The mathematical relationship is: $$\text{Loading Dose} = V_d \times \text{Target } C_p$$ Since the goal of a loading dose is to "fill up" the body's various compartments (tissues and plasma) to reach a steady state immediately, the drug's distribution characteristics ($V_d$) are the most critical factor. **Analysis of Options:** * **B. Clearance (CL):** This determines the **Maintenance Dose (MD)**, which is the dose required to replace the drug being eliminated to maintain a steady state. * **C. Rate of Administration:** While important for safety (to avoid toxicity from rapid IV push), it does not determine the calculated dose required to reach a target concentration. * **D. Half-life ($t_{1/2}$):** This determines the **time taken** to reach steady state (usually 4–5 half-lives) without a loading dose, but it does not dictate the size of the loading dose itself. **High-Yield Clinical Pearls for NEET-PG:** 1. **Loading Dose** = Rapidly reaches therapeutic levels; **Maintenance Dose** = Maintains steady state. 2. **Renal/Hepatic Failure:** In these conditions, clearance is reduced, so the **Maintenance Dose must be decreased**. However, the **Loading Dose remains the same** (unless the $V_d$ is significantly altered). 3. **Digoxin and Amiodarone:** These are classic examples of drugs requiring loading doses due to their large $V_d$ and long half-lives. 4. **Bioavailability (F):** If a drug is given orally, the formula becomes: $LD = (V_d \times \text{Target } C_p) / F$.

Question 24: Which of the following statements regarding plasma protein binding is NOT true?

A. The free fraction of a drug is considered pharmacologically active.
B. Acidic drugs typically bind to plasma albumin.
C. Nephrotic syndrome does not affect plasma protein binding. (Correct Answer)
D. Prazosin is bound to alpha-1-acid glycoprotein.

Explanation: ### Explanation **1. Why Option C is the Correct Answer (The "NOT True" Statement):** Plasma protein binding is significantly altered in **Nephrotic Syndrome**. This condition is characterized by massive proteinuria, leading to **hypoalbuminemia**. Since many drugs (especially acidic ones) rely on albumin for transport, a decrease in albumin levels results in a higher **free fraction** of the drug. This can lead to increased pharmacological effects or potential toxicity even at standard doses. Therefore, saying it "does not affect" binding is medically incorrect. **2. Analysis of Incorrect Options:** * **Option A:** This is a fundamental principle. Only the **free (unbound) fraction** can cross biological membranes, interact with receptors, and undergo metabolism/excretion. The bound fraction acts as a reservoir. * **Option B:** Generally, **acidic drugs** (e.g., NSAIDs, Warfarin, Phenytoin) bind to **Albumin**, while **basic drugs** (e.g., Lidocaine, Propranolol) bind to **Alpha-1-acid glycoprotein (AAG)**. * **Option D:** Prazosin is a basic drug. Basic drugs predominantly bind to **Alpha-1-acid glycoprotein**, making this statement true. **3. High-Yield Clinical Pearls for NEET-PG:** * **Albumin vs. AAG:** Albumin levels decrease in liver disease and nephrotic syndrome. AAG is an "acute-phase reactant"; its levels **increase** during inflammation, surgery, or myocardial infarction, potentially decreasing the free fraction of basic drugs. * **Displacement Interactions:** Highly protein-bound drugs (e.g., Warfarin) can be displaced by other drugs (e.g., Sulfonamides), leading to a sudden spike in the free fraction and toxicity. * **Volume of Distribution (Vd):** Drugs with high plasma protein binding typically have a **low Vd**, as they are sequestered within the vascular compartment.

Question 25: What is true about intracellular receptors?

A. They are mainly on the nuclear surface. (Correct Answer)
B. Growth hormone acts on them.
C. Estrogen does not act on them.
D. All of the above.

Explanation: **Explanation:** Intracellular receptors (also known as nuclear receptors) are a class of receptors located inside the cell, rather than on the plasma membrane. These receptors function as ligand-activated transcription factors. **1. Why Option A is correct:** Intracellular receptors are located either in the **cytoplasm** (e.g., glucocorticoids, mineralocorticoids) or directly in the **nucleus** (e.g., estrogen, thyroid hormones). Even cytoplasmic receptors, once bound to their ligand, must translocate to the nucleus to bind to specific DNA sequences (Hormone Response Elements). Therefore, their primary site of action and predominant location for gene regulation is the **nuclear surface/matrix.** **2. Why the other options are incorrect:** * **Option B:** Growth hormone (GH) is a peptide hormone. It acts via **cell surface receptors** (specifically, JAK-STAT kinase-linked receptors), not intracellular receptors. * **Option C:** Estrogen is a steroid hormone. Being lipophilic, it easily crosses the cell membrane and acts specifically on **intracellular (nuclear) receptors** to regulate gene expression. **NEET-PG High-Yield Pearls:** * **Mnemonic for Intracellular Receptors:** **"VET CAPS"** – **V**itamin A & D, **E**strogen, **T**hyroid hormone (T3/T4), **C**ortisol (Glucocorticoids), **A**ldosterone (Mineralocorticoids), **P**rogesterone, and **S**ex hormones (Testosterone). * **Mechanism:** These receptors have a specific **Zinc-finger motif** in their DNA-binding domain. * **Lag Period:** Because they act by altering protein synthesis (transcription/translation), their effects have a slow onset (hours to days) and a long duration of action.

Question 26: Which of the following is the 'ordeal poison' used by tribes of Africa?

A. Physostigmine (Correct Answer)
B. Digoxin
C. Cocaine
D. Atropine

Explanation: **Explanation:** **Physostigmine (Option A)** is the correct answer. It is a naturally occurring tertiary amine carbamate obtained from the **Calabar bean** (*Physostigma venenosum*). Historically, these beans were used by West African tribes in "trials by ordeal" to determine guilt or innocence. A person accused of a crime would ingest the beans; if they vomited (survived), they were declared innocent, but if they succumbed to the toxic effects (miosis, skeletal muscle paralysis, and respiratory failure), they were deemed guilty. **Why the other options are incorrect:** * **Digoxin (Option B):** A cardiac glycoside derived from *Digitalis lanata*. It is used for heart failure and atrial fibrillation but has no historical association with ordeal trials. * **Cocaine (Option C):** An alkaloid from *Erythroxylum coca* used as a local anesthetic and drug of abuse; it acts as a sympathomimetic. * **Atropine (Option D):** An anticholinergic derived from *Atropa belladonna*. Interestingly, it is the **pharmacological antidote** for physostigmine poisoning, as it competes at muscarinic receptors. **High-Yield NEET-PG Pearls:** * **Lipid Solubility:** Unlike Neostigmine, Physostigmine is a **tertiary amine**, meaning it is lipid-soluble and **crosses the blood-brain barrier (BBB)**. * **Clinical Use:** It is the drug of choice for **Atropine poisoning** (Anticholinergic syndrome). * **Mechanism:** It is a reversible anticholinesterase that increases acetylcholine levels at both muscarinic and nicotinic sites. * **Mnemonic:** "Physostigmine **P**hixes (fixes) the **P**eriphery and the **P**syche (CNS)."

Question 27: Which schedule of drug is to be sold only on prescription?

A. H (Correct Answer)
B. P
C. G
D. X

Explanation: ### Explanation In India, the **Drugs and Cosmetics Rules (1945)** categorize drugs into various "Schedules" to regulate their manufacture, sale, and labeling. **Correct Option: A (Schedule H)** Schedule H contains a list of drugs that are classified as **prescription-only drugs**. These cannot be sold over the counter (OTC) and must be dispensed only by a licensed pharmacist upon the presentation of a valid prescription from a Registered Medical Practitioner (RMP). The drug container must display the symbol **'Rx'** and a warning stating it is not to be sold without a prescription. **Analysis of Incorrect Options:** * **Option B (Schedule P):** This schedule specifies the **expiry period** (shelf life) and storage conditions for various drugs (e.g., Insulin, Antibiotics). * **Option C (Schedule G):** These are drugs that must be taken only under **medical supervision** (e.g., Metformin, Antihistamines). They do not necessarily require a prescription for every sale in the same way Schedule H does, but their labels must carry a cautionary note: *"Caution: It is dangerous to take this preparation except under medical supervision."* * **Option D (Schedule X):** This schedule includes **Narcotic and Psychotropic drugs** (e.g., Ketamine, Amphetamines). While they also require a prescription, they are subject to much more stringent controls than Schedule H, including the requirement for the pharmacist to maintain a duplicate copy of the prescription for two years. **High-Yield Clinical Pearls for NEET-PG:** * **Schedule H1:** Introduced in 2013 to curb antibiotic resistance; it includes 3rd/4th gen Cephalosporins, Anti-TB drugs, and certain habit-forming drugs. * **Schedule Y:** Guidelines for **Clinical Trials** (import/manufacture of new drugs). * **Schedule N:** List of minimum **equipment** required for an efficient pharmacy. * **Schedule J:** List of diseases/ailments which a drug may not purport to prevent or cure (e.g., AIDS, Cancer, Genetic disorders).

Question 28: Which of the following is not an enzyme inhibitor?

A. Isoniazid
B. Ketoconazole
C. Griseofulvin (Correct Answer)
D. Acute alcohol intoxication

Explanation: ### Explanation The correct answer is **Griseofulvin** because it is a potent **microsomal enzyme inducer**, not an inhibitor. #### 1. Why Griseofulvin is the Correct Answer In pharmacology, drugs that affect the Cytochrome P450 (CYP450) system are classified as either inducers or inhibitors. **Griseofulvin** increases the synthesis of microsomal enzymes. This leads to the accelerated metabolism of co-administered drugs (like warfarin or oral contraceptives), potentially reducing their therapeutic efficacy. #### 2. Analysis of Incorrect Options (Enzyme Inhibitors) The other options are classic examples of enzyme inhibitors, which decrease CYP450 activity, leading to increased plasma levels and potential toxicity of other drugs: * **Isoniazid (INH):** A primary anti-tubercular drug known to inhibit enzymes, often leading to interactions with phenytoin. * **Ketoconazole:** An antifungal that strongly inhibits CYP3A4; it is a frequent "distractor" in exam questions regarding drug interactions. * **Acute Alcohol Intoxication:** Acute ingestion of alcohol competes for metabolic pathways and inhibits the metabolism of other drugs. (Note: *Chronic* alcohol consumption is an enzyme inducer). #### 3. High-Yield Clinical Pearls for NEET-PG To quickly solve "Inducer vs. Inhibitor" questions, remember these mnemonics: * **Enzyme Inducers (GPRS Cell Phone):** * **G**riseofulvin * **P**henytoin / **P**henobarbitone * **R**ifampicin (Strongest inducer) * **S**moking / **S**t. John’s Wort * **C**arbamazepine * **Enzyme Inhibitors (VITAMIN K):** * **V**alproate * **I**soniazid * **T**amoxifen * **A**miodarone * **M**acrolides (except Azithromycin) * **I**ndinavir * **N**efazodone * **K**etoconazole (and other Azoles) * *Also: Cimetidine, Grapefruit juice, and Acute Alcohol.*

Question 29: An investigator is studying a potential new antiarrhythmic. Eighty healthy test subjects are receiving various doses of the drug. Adverse effects and the drug’s pharmacokinetics are assessed. Which of the following steps in the drug development process does this represent?

A. New drug application (NDA)
B. Phase I (Correct Answer)
C. Phase II
D. Phase III

Explanation: ### Explanation **Correct Answer: B. Phase I** The scenario describes **Phase I clinical trials**, which are the first stage of testing a new drug in humans [1]. The primary goal of Phase I is to assess **safety, tolerability, and pharmacokinetics** (ADME: Absorption, Distribution, Metabolism, and Excretion) [3]. **Why Phase I is correct:** * **Subjects:** It typically involves a small group (**20–100**) of **healthy volunteers** [3] (except for highly toxic drugs like anti-cancer agents, where patients are used). * **Objective:** To determine the maximum tolerated dose and identify common side effects [3]. The mention of "80 healthy test subjects" and "pharmacokinetics" are classic indicators of Phase I. **Why other options are incorrect:** * **Phase II:** Focuses on **efficacy** ("proof of concept") [1] and optimal dosing in a small group of **patients** (100–300) who actually have the disease. * **Phase III:** Involves large-scale, multicenter, randomized controlled trials (RCTs) in **thousands of patients** to confirm efficacy and monitor for rarer adverse effects compared to existing treatments. * **New Drug Application (NDA):** This is the formal proposal submitted to regulatory authorities (like the FDA or DCGI) *after* Phase III is successfully completed [1] to gain marketing approval. --- ### High-Yield Clinical Pearls for NEET-PG * **Phase 0 (Microdosing):** Uses sub-therapeutic doses in <15 humans to study pharmacokinetics; it precedes Phase I. * **Phase IV (Post-marketing Surveillance):** Occurs after the drug is on the market to detect rare or long-term adverse effects (e.g., Phocomelia with Thalidomide) [2]. * **Trick for Subjects:** * Phase I = **H**ealthy volunteers (**H**ow safe?) * Phase II = **P**atients (**P**roof of concept) * Phase III = **L**arge scale (**L**egality/Approval) * **Success Rate:** Phase I has the highest success rate (~70%), while Phase II has the highest failure rate due to lack of efficacy [1].

Question 30: What is the advantage of a fixed-dose combination of drugs?

A. Increases efficacy of drug
B. Decreases adverse effects
C. Patient compliance improved
D. All of the above (Correct Answer)

Explanation: Fixed-Dose Combinations (FDCs) involve two or more active pharmacological ingredients in a single pharmaceutical formulation. They are widely used in the management of chronic conditions like Hypertension, Diabetes, HIV, and Tuberculosis. **Why "All of the Above" is Correct:** 1. **Increases Efficacy (Option A):** FDCs often utilize **synergistic or additive effects** [4]. For example, combining a Sulfonylurea with Metformin targets two different pathological pathways of Diabetes, achieving better glycemic control than either drug alone at higher doses. 2. **Decreases Adverse Effects (Option B):** By combining drugs, one can often use lower doses of each component to achieve the same therapeutic effect, thereby reducing dose-dependent side effects [2]. Additionally, one drug may counteract the side effects of another (e.g., adding an ACE inhibitor to a Dihydropyridine Calcium Channel Blocker reduces the risk of peripheral edema). 3. **Improves Patient Compliance (Option C):** This is the most significant clinical advantage [1]. Reducing the **"pill burden"** simplifies the treatment regimen, making it easier for patients to adhere to their medication schedule, which is crucial for long-term outcomes [3]. **High-Yield NEET-PG Pearls:** * **Rational vs. Irrational FDCs:** A rational FDC must have ingredients that act by different mechanisms, have similar pharmacokinetics (half-lives), and should not lead to increased toxicity. * **Disadvantage:** The primary drawback of FDCs is the **lack of flexibility** in adjusting the dose of an individual component (titration difficulty). * **Classic Example:** Levodopa + Carbidopa. Carbidopa (a peripheral decarboxylase inhibitor) increases the efficacy of Levodopa in the CNS while decreasing peripheral side effects like nausea and vomiting.

Practice by Chapter

Pharmacokinetics: Absorption and Distribution

Practice Questions

Pharmacokinetics: Metabolism and Excretion

Practice Questions

Pharmacodynamics and Receptor Theory

Practice Questions

Drug-Receptor Interactions and Dose-Response

Practice Questions

Pharmacogenetics and Personalized Medicine

Practice Questions

Adverse Drug Reactions and Toxicity

Practice Questions

Drug Interactions

Practice Questions

Drug Development and Regulation

Practice Questions

Pediatric and Geriatric Pharmacology

Practice Questions

Placental Transfer and Lactation

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free